聯系電話
上海起發實驗試劑有限公司
中級會員·16年
- 聯系人：
- 楊經理
- 電話：
- 021-50724187 021-50724961
- 手機：
- 15921799099
- 傳真：
- 021-50724961
- 地址：
- 上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
- 個性化：
- www.qfbio.com
- 網址：
- www.qfbio.com
掃一掃訪問手機商鋪
 提 供 商 |
上海起發實驗試劑有限公司 |  資料大小 |
2.8MB |
|---|---|---|---|
 資料類型 |
PDF 文件 |  資料圖片 |
|
 下載次數 |
83次 |  瀏覽次數 |
3279次 |
Abbexa SARS-CoV-2抗原快速檢測試劑盒簡介
我們還提供專業使用的cov-19抗原檢測試劑盒。這是一種用于實驗室和醫院檢測的一次性體外診斷設備。這款包羅萬象的套件僅需10分鐘即可產生快速、直觀的效果。
這是一種定性的橫向流動免疫層析法，用于檢測人口咽、鼻和鼻咽拭子中的SARSCoV-2抗原。
該盒含有與金納米顆粒結合的抗SARS-CoV-2/COVID19單克隆抗體，金納米顆粒與樣本中存在的任何SARS-CoV-2抗原結合。抗SARS-CoV-2的單克隆抗體被包裹在硝化纖維素膜上的測試區域，該膜與抗原抗體復合物結合，并由于金納米顆粒而形成彩色線。盒式磁帶上端的控制區域確認測試是否成功。
讀數應在C（控制）區域顯示1行。根據接觸冠狀病毒的情況，G（IgG）和M（IgM）區域旁邊可能出現紫色線。微弱的線條被視為陽性結果
SARS-CoV-2逆轉錄定量PCR試劑盒
Abbexa也很高興向客戶提供我們的qPCR套件。
嚴重急性呼吸綜合征冠狀病毒2（SARS-CoV-2/COVID19）RT-qPCR試劑盒，用于在單管中高效合成cDNA和實時PCR。
該試劑盒包含一組熒光探針引物，用于區分2019 nCoV/COVID19/SARS-CoV-2和SARS-CoV（bat SARS相關CoV）。SARS-CoV-2 RNA可在FAM通道中檢測到，SARS-CoV RNA可在HEX、VIC或JOE通道中檢測到（取決于所用設備）。
| COVID19 Kits | |||
| Catalogue Number | Product Name | Description | |
| abx365044 | Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Neutralizing Antibodies in Human serum and plasma. | |
| abx365086 | Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | For the semi-quantitative detection of SARS-CoV-2/COVID19 Neutralizing Antibodies in Human serum and plasma. | |
| abx392294 | Human SARS-CoV-2 Nucleocapsid Protein IgG ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein IgG antibodies in Human serum and plasma. | |
| abx392295 | Human SARS-CoV-2 Nucleocapsid Protein IgM ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein IgM antibodies in Human serum and plasma. | |
| abx365028 | Human SARS-CoV-2 Spike Protein IgG ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein IgG antibodies in Human serum and plasma. | |
| abx365029 | Human SARS-CoV-2 Spike Protein IgM ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein IgM antibodies in Human serum and plasma. | |
| abx365085 | Human SARS-CoV-2 Spike Protein Total Antibody ELISA Kit | For the qualitative detection of SARS-CoV-2/COVID19 Spike Protein total antibodies in Human serum and plasma. | |
| abx365030 | SARS-CoV-2 Nucleocapsid Protein ELISA Kit | For the quantitative detection of SARS-CoV-2/COVID19 Nucleocapsid Protein in Hu- man serum, plasma and other biological fluids. | |
| abx365031 | SARS-CoV-2 Spike Protein S1 RBD ELISA Kit | For the quantitative detection of SARS-CoV-2/COVID19 Spike Protein S1 RBD in Human tissue homogenates, cell lysates, cell culture supernatants, saliva, and other biological fluids. | |
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| Beta (South Africa) B.1.351 Variant - K417N, E484K and N501Y Mutations | |||
| The Beta (B.1.351) variant was first identified in South Africa. It contains the K417N, E484K and N501Y mutations in the spike protein’s receptor-binding domain. | |||
| Catalogue Number | Product Name | Description | |
| abx160085 | SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) | Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. | |
| abx620004 | SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Gamma (Brazil) P.1 Variant - K417T, E484K and N501Y Mutations | |||
| The Gamma (P.1) variant was first identified in Brazil. It contains the K417T, E484K and N501Y mutations in the spike protein’s receptor-binding domain. | |||
| Catalogue Number | Product Name | Description | |
| abx160086 | SARS-CoV-2 S1 Protein RBD (Gamma P.1 Variant) | Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. | |
| abx620006 | SARS-CoV-2 Spike Protein RBD (Gamma P.1 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Epsilon (California) B.1.429/B.1.427 (CAL.20C) Variant - L452R Mutation | |||
| The L452R mutation is present in the B.1.429/B.1.427 (CAL.20C/Epsilon) variants first identified in California, USA. | |||
| Catalogue Number | Product Name | Description | |
| abx160087 | SARS-CoV-2 S1 Protein RBD (L452R Mutation) | Recombinant protein expressed in Insect cells. Tag: C-terminal His-tag. | |
| abx620007 | SARS-CoV-2 Spike Protein RBD (L452R Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| India B.1.36 (AP) Variant — N450K Mutation | |||
| The N450K mutation is present in the B.1.36 variant first identified in Andhra Pradesh, India. | |||
| Catalogue Number | Product Name | Description | |
| abx620011 | SARS-CoV-2 Spike Protein RBD (N450K Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Kappa (India) B.1.617.1 Variant — E484Q and L452R Double-Mutation | |||
| The B.1.617 variant was first identified in India. It contains the E484Q and L452R mutations and is therefore widely known as a “double mutation" variant. These mutations have been reported to increase binding to human ACE2 and reduce antibody neutralization of the virus, in comparison with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx160088 | SARS-CoV-2 S1 Protein RBD (B.1.617 Variant) | Recombinant protein expressed in Insect cells. Tag: His-tag. | |
| abx620009 | SARS-CoV-2 Spike Protein RBD (B.1.617 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Delta (India) B.1.617.2 Variant — L452R and T478K Double-Mutation | |||
| The B.1.617.2 (Delta) variant was first identified in India. It contains the L452R and T478K mutations, which appear to increase viral infectivity compared with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx620012 | SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Mutant SARS-CoV-2 Recombinant Proteins | |||
| Delta Plus B.1.617.2 (AY.1) Variant — K417N, L452R and T478K Mutations | |||
| The B.1.617.2.1 (Delta Plus) variant, also known as AY.1, contains the K417N mutation as well as the L452R and T478K mutations in the original B.1.617.2 (Delta) variant. These mutations appear to increase viral infectivity compared with other variants. | |||
| Catalogue Number | Product Name | Description | |
| abx620018 | SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| Other Mutations | |||
| The E484K mutation is present in several variants, including those first identified in South Africa and Brazil. This mutation has been reported to reduce antibody neutralization of the virus. The S477N mutation has been reported to increase binding to human ACE2. | |||
| Catalogue Number | Product Name | Description | |
| abx620005 | SARS-CoV-2 Spike Protein RBD (E484K Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| abx620008 | SARS-CoV-2 Spike Protein RBD (S477N Mutation) | Recombinant protein expressed in Mammalian cells. Tag: C-terminal His-tag. | |
| SARS-CoV-2 Antibody Pairs | |||
| Catalogue Number | Product Name | Description | |
| abx024239 | SARS-CoV-2/COVID19 Nucleocapsid Protein Antibody | Mouse Monoclonal against SARS-CoV-2/ COVID19 NP (Capture Antibody) | |
| abx024238 | SARS-CoV-2/COVID19 Nucleocapsid Protein Antibody | Mouse Monoclonal against SARS-CoV-2/ COVID19 NP (Detection Antibody) | |
| abx024240 | SARS-CoV-2/COVID19 Trimer- ic Spike 1 Protein Antibody | Mouse Monoclonal against SARS-CoV-2/ COVID19 Trimeric S1 Protein (Capture Antibody) | |
| abx024241 | SARS-CoV-2/COVID19 Trimer- ic Spike 1 Protein Antibody | Mouse Monoclonal against SARS-CoV-2/ COVID-9 Trimeric S1 Protein (Detection Antibody) | |
| abx243136 | SARS-CoV-2/COVID19 Spike Glycoprotein RBD Antibody Pair | Contains a recombinant Llama with Human IgG1 Fc capture antibody, and recombinant Mouse with Human IgG1 Fc detection antibody. | |
